165 related articles for article (PubMed ID: 9696914)
1. [Prospective evaluation of antidepressant discontinuation].
Mourad I; Lejoyeux M; Adès J
Encephale; 1998; 24(3):215-22. PubMed ID: 9696914
[TBL] [Abstract][Full Text] [Related]
2. [Depressive symptomatology and sleep apnea syndrome].
Pochat MD; Ferber C; Lemoine P
Encephale; 1993; 19(6):601-7. PubMed ID: 12404778
[TBL] [Abstract][Full Text] [Related]
3. [Antidepressants consumption in the global population in France].
Olié JP; Elomari F; Spadone C; Lépine JP
Encephale; 2002; 28(5 Pt 1):411-7. PubMed ID: 12386542
[TBL] [Abstract][Full Text] [Related]
4. [Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city].
Mouchabac S; Ferreri M; Cabanac F; Bitton M
Encephale; 2003; 29(5):438-44. PubMed ID: 14615693
[TBL] [Abstract][Full Text] [Related]
5. Potential adverse effects of discontinuing psychotropic drugs: part 2: antidepressant drugs.
Howland RH
J Psychosoc Nurs Ment Health Serv; 2010 Jul; 48(7):9-12. PubMed ID: 20608581
[TBL] [Abstract][Full Text] [Related]
6. The abrupt discontinuation of fluvoxamine in patients with panic disorder.
Black DW; Wesner R; Gabel J
J Clin Psychiatry; 1993 Apr; 54(4):146-9. PubMed ID: 8486592
[TBL] [Abstract][Full Text] [Related]
7. Compliance with antidepressants in a primary care setting, 2: the influence of gender and type of impairment.
Demyttenaere K; Enzlin P; Dewé W; Boulanger B; De Bie J; De Troyer W; Mesters P
J Clin Psychiatry; 2001; 62 Suppl 22():34-7. PubMed ID: 11599646
[TBL] [Abstract][Full Text] [Related]
8. The effects of bifemelane hydrochloride on depressive illness of the elderly.
Yamagami S; Koide S; Mui K; Perk S; Hirayama E; Kioka T; Soejima K; Inoue K; Nishiwaki S
Int J Clin Pharmacol Res; 1995; 15(1):1-7. PubMed ID: 7490169
[TBL] [Abstract][Full Text] [Related]
9. Social anxiety symptoms across diagnoses among outpatients attending a tertiary care mood and anxiety disorders service.
Graystone HJ; Garner MJ; Baldwin DS
J Affect Disord; 2009 Apr; 114(1-3):305-9. PubMed ID: 18656267
[TBL] [Abstract][Full Text] [Related]
10. The effect of anxiety disorder comorbidity on treatment resistant bipolar disorders.
Lee JH; Dunner DL
Depress Anxiety; 2008; 25(2):91-7. PubMed ID: 17311265
[TBL] [Abstract][Full Text] [Related]
11. Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression.
Wichniak A; Brunner H; Ising M; Pedrosa Gil F; Holsboer F; Friess E
Psychoneuroendocrinology; 2004 Oct; 29(9):1101-8. PubMed ID: 15219633
[TBL] [Abstract][Full Text] [Related]
12. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy.
Akiskal HS; Benazzi F; Perugi G; Rihmer Z
J Affect Disord; 2005 Apr; 85(3):245-58. PubMed ID: 15780694
[TBL] [Abstract][Full Text] [Related]
13. [Withdrawal syndrome from antidepressive drugs. Report of 5 cases].
Lejoyeux M; Rodière-Rein C; Adès J
Encephale; 1992; 18(3):251-5. PubMed ID: 1299596
[TBL] [Abstract][Full Text] [Related]
14. Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.
Malhi GS; Ng F; Berk M
Aust N Z J Psychiatry; 2008 Apr; 42(4):346-9. PubMed ID: 18330778
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of antidepressant treatments in pre-menopausal versus post-menopausal women: a pilot study on differential effects of sex hormones on antidepressant effects.
Pae CU; Mandelli L; Kim TS; Han C; Masand PS; Marks DM; Patkar AA; Steffens DC; De Ronchi D; Serretti A
Biomed Pharmacother; 2009 Mar; 63(3):228-35. PubMed ID: 18502089
[TBL] [Abstract][Full Text] [Related]
16. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
17. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
Alpert JE; Franznick DA; Hollander SB; Fava M
J Clin Psychiatry; 2004 Aug; 65(8):1069-75. PubMed ID: 15323591
[TBL] [Abstract][Full Text] [Related]
18. Milnacipran and pindolol: a randomized trial of reduction of antidepressant latency.
Isaac MT; Isaac MB; Gallo F; Tournoux A
Hum Psychopharmacol; 2003 Dec; 18(8):595-601. PubMed ID: 14696018
[TBL] [Abstract][Full Text] [Related]
19. Treatment of depression--newer pharmacotherapies.
Mulrow CD; Williams JW; Trivedi M; Chiquette E; Aguilar C; Cornell JE; Badgett R; Noël PH; Lawrence V; Lee S; Luther M; Ramirez G; Richardson WS; Stamm K
Psychopharmacol Bull; 1998; 34(4):409-795. PubMed ID: 10513454
[TBL] [Abstract][Full Text] [Related]
20. Effects of ropinirole on nonmotor symptoms of Parkinson disease: a prospective multicenter study.
Rektorova I; Balaz M; Svatova J; Zarubova K; Honig I; Dostal V; Sedlackova S; Nestrasil I; Mastik J; Bares M; Veliskova J; Dusek L
Clin Neuropharmacol; 2008; 31(5):261-6. PubMed ID: 18836343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
